Literature DB >> 6370405

IgG4 as a blocking antibody.

R C Aalberse, P H Dieges, V Knul-Bretlova, P Vooren, M Aalbers, J van Leeuwen.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6370405     DOI： 10.1007/bf02991163

Source DB:  PubMed          Journal:  Clin Rev Allergy        ISSN： 0731-8235


× No keyword cloud information.
  9 in total

1.  The IgG subclasses of antibodies to grass pollen allergens produced in hay fever patients during hyposensitization.

Authors:  M E Devey; D V Wilson; A W Wheeler
Journal:  Clin Allergy       Date:  1976-05

2.  Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy.

Authors:  M van der Giessen; W L Homan; G van Kernbeek; R C Aalberse; P H Dieges
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

3.  Immunologic changes during specific treatment of the atopic state. I. Allergen binding capacity of atopic sera in the course of hyposensitization treatment.

Authors:  V Zavázal; A Stajner
Journal:  Acta Allergol       Date:  1970-04

4.  IgG4 and release of histamine from human peripheral blood leukocytes.

Authors:  A W van Toorenenbergen; R C Aalberse
Journal:  Int Arch Allergy Appl Immunol       Date:  1982

5.  Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response.

Authors:  R C Aalberse; R van der Gaag; J van Leeuwen
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

6.  IgE and IgG4 antibodies in specific human allergies.

Authors:  P L Bruynzeel; L Berrens
Journal:  Int Arch Allergy Appl Immunol       Date:  1979

7.  Interference in ragweed pollen and honeybee venom radioallergosorbent tests.

Authors:  E M Zimmermann; J W Yunginger; G J Gleich
Journal:  J Allergy Clin Immunol       Date:  1980-11       Impact factor: 10.793

8.  The IgG subclasses of antibodies to castor bean allergen in patients with allergic asthma: detection of a high incidence of antibodies of the IgG4 subclass.

Authors:  M E Devey; R Panzani
Journal:  Clin Allergy       Date:  1975-12

9.  Immuno-enzymatic study of IgG subclasses specific for allergen in house dust immediate hypersensitivity.

Authors:  M Etievant; B Leluc; R Bouclier; E Henocq
Journal:  Ann Allergy       Date:  1979-09
  9 in total
  24 in total

1.  Immunoglobulin subclass profiles of anti-idiotypic antibodies to GAD65Ab differ between type 1 diabetes patients and healthy individuals.

Authors:  S Oak; J Radtke; C Törn; M Landin-Olsson; C S Hampe
Journal:  Scand J Immunol       Date:  2011-10       Impact factor: 3.487

Review 2.  Allergen immunotherapy. When is it useful?

Authors:  R H Loblay
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

3.  Allergen-specific IgG antibody levels modify the relationship between allergen-specific IgE and wheezing in childhood.

Authors:  Adnan Custovic; Lars Soderstrom; Staffan Ahlstedt; Peter D Sly; Angela Simpson; Patrick G Holt
Journal:  J Allergy Clin Immunol       Date:  2011-04-13       Impact factor: 10.793

4.  IgG subclasses in human chronic schistosomiasis: over-production of schistosome-specific and non-specific IgG4.

Authors:  F N Boctor; J B Peter
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

5.  Normal human immunoglobulin G4 is bispecific: it has two different antigen-combining sites.

Authors:  J Schuurman; R Van Ree; G J Perdok; H R Van Doorn; K Y Tan; R C Aalberse
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

Review 6.  IgG4 breaking the rules.

Authors:  Rob C Aalberse; Janine Schuurman
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

Review 7.  Current status of allergen immunotherapy (hyposensitization): memorandum from a WHO/IUIS meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

8.  Evaluation and characterization of Fasciola hepatica tegument protein extract for serodiagnosis of human fascioliasis.

Authors:  Adelaida Morales; Ana M Espino
Journal:  Clin Vaccine Immunol       Date:  2012-09-26

9.  [From the allergen-recognition by antibodies to new therapeutic concepts].

Authors:  Brigitte Hantusch; Erika Jensen-Jarolim
Journal:  Wien Med Wochenschr       Date:  2008

10.  Disodium cromoglycate (DSCG) selectively inhibits IgE production and enhances IgG4 production by human B cell in vitro.

Authors:  H Kimata; A Yoshida; C Ishioka; H Mikawa
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.